Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
289 Leser
Artikel bewerten:
(1)

Lief Labs Announces Launch of Its Lief Raws Nutraceutical Ingredient Supplier Division

Lief Raws offers an innovative, solutions-driven approach from ideation to delivery of science-focused performance ingredients

VALENCIA, CA / ACCESSWIRE / February 8, 2022 / Lief Labs, a premier formulation and product development innovator and manufacturer of dietary supplements, is pleased to announce the launch of its Lief Raws division, a quality-driven and science-focused performance ingredient supplier providing forward-thinking ingredients to the continuously adapting nutraceuticals market. The premium products available through Lief Raws include innovative, in-house developed ingredients, as well as specialty ingredients through Lief Raws' collaborative partnerships with trusted brands.

Lief Raws provides sales and distribution services and a range of full-service capabilities to its partners, including product formulation, scientific education, marketing, and ideation development. Lief Raws also features its Lief Evolutions offerings, which provide innovative product formats, such as functionality and experiential technologies, designed to enable Lief Raws' customers to have a novel point of differentiation in the marketplace. Lief Evolutions' first offering is Biozomal, which is a liposomal technology. This liposomal technology can be applied to a range of ingredients, including caffeine, zinc, vitamin C, and iron, among others.*

The featured specialty ingredients currently available through Lief Raws, include:

  • Biozomal Caffeine
  • CeleVida Celery Powder
  • CellFlo6 Green Tea Extract
  • flolí Organic Rice-based Excipient Blend
  • Kocha Bucha Kombucha Powder
  • oatzi Oatmilk Powder
  • Actiponin® Patented Jiaogulan Extract (Coming Soon)

"We developed Lief Raws with the needs of our customers, vendors, and end-consumers strongly in mind, and a goal of delivering an elevated experience that goes well beyond traditional ingredients and delivery formats," said Tito Sanchez, Senior Sales Executive for Lief Raws. "Our practice of continuously engaging with, and truly listening to our partners, enables us to understand their evolving needs and strategically determine the new ingredients, formats and innovations we should pursue. We are very excited to introduce Lief Raws and a robust line-up of ingredients and delivery formats to the nutraceuticals marketplace, and we look forward to continuing to grow our partnership base."

For more information about Lief Raws and its distribution and sales services, contact info@liefraws.com.

About Lief Labs

Lief Labs is a premier formulation and product development innovator and manufacturer of dietary supplements. Our in-house Product Development and R&D team creates the best tasting and most cutting-edge formulations of supplements. Lief also houses over 220,000 sq ft of new and fully renovated, full-service, state-of-the-art, Current Good Manufacturing Practice (cGMP) manufacturing facility, which includes an in-house analytical testing lab and a microbiology lab, and offers custom solutions for a multitude of supplement categories. Lief collaborates with entrepreneurial firms to help them build premier brands. Our turnkey solutions allow us to engage in seamless partnerships that help brands with scalability and sustainable growth. The company is based in Valencia, CA. To learn more, please visit https://www.lieflabs.com/.

About Lief Raws

Lief Raws, a division of Lief Labs, is a quality-driven and science-focused performance ingredient supplier providing forward thinking ingredients to the continuously adapting market. Lief Raws provides sales and distribution services and a range of full-service capabilities to its partners, including product formulation, scientific education, marketing, and ideation development. As a partner in product development, we will help transform ideas into reality. Lief Raws was founded on the premise of creating and delivering innovative ingredient and delivery solutions to the nutraceutical industries. We build partnerships and establish trust with our customers by devoting our efforts towards customer service, quality, and collaborative innovation. Lief Raws is based in Valencia, CA. To learn more about Lief Raws, please visit us on our website: https://liefraws.com/ and on LinkedIn and Instagram.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
For Media Inquiries, please contact:
Cathy Loos
Loos & Co. Communications
+1-347-334-4135
cloos@looscomm.com

SOURCE: Lief Labs



View source version on accesswire.com:
https://www.accesswire.com/687734/Lief-Labs-Announces-Launch-of-Its-Lief-Raws-Nutraceutical-Ingredient-Supplier-Division

© 2022 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.